Back to Search
DAVID CURIEL, MD, PHD
MD, PHD
Pulmonary Disease Physician
NPI: 1851807291Individual
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
17873(AL)2014018786(MO)
Research & Publications (20)
Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirus.
PMID 19524222·Fertil Steril·2010
7-preclinical
Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy.
PMID 19395305·Drug Resist Updat·2009
6-review
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
PMID 19509153·Clin Cancer Res·2009
7-preclinical
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.
PMID 19417161·Mol Cancer Ther·2009
8-other
Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.
PMID 19285990·J Mol Biol·2009
8-other
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24.
PMID 19276652·Cancer Biol Ther·2009
6-review
Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
PMID 19147569·Cancer Res·2009
7-preclinical
Promotion of incisional wound repair by human mesenchymal stem cell transplantation.
PMID 18803656·Exp Dermatol·2009
7-preclinical
Advancements in adenoviral based virotherapy for ovarian cancer.
PMID 19422865·Adv Drug Deliv Rev·2009
6-review
Characterization of infectivity of knob-modified adenoviral vectors in glioma.
PMID 18756624·Cancer Biol Ther·2008
7-preclinical
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95.
PMID 18790746·Mol Cancer Ther·2008
7-preclinical
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid.
PMID 18786542·J Mol Biol·2008
7-preclinical
Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation.
PMID 18765530·Clin Cancer Res·2008
8-other
Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
PMID 18718011·Virol J·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4950 CHILDRENS PL STE 10130
SAINT LOUIS, MO 63110 - Phone
- (314) 747-5443
Quick Facts
- NPI
- 1851807291
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile